标题
Regulatory cells and the effect of cancer immunotherapy
作者
关键词
-
出版物
Molecular Cancer
Volume 22, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-02-04
DOI
10.1186/s12943-023-01714-0
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity
- (2022) Kebria Hezaveh et al. IMMUNITY
- CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory
- (2022) Yujiro Kidani et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An Fc-Competent Anti-Human TIGIT Blocking Antibody Ociperlimab (BGB-A1217) Elicits Strong Immune Responses and Potent Anti-Tumor Efficacy in Pre-Clinical Models
- (2022) Xin Chen et al. Frontiers in Immunology
- Anti-CCR4 treatment depletes regulatory T cells and leads to clinical activity in a canine model of advanced prostate cancer
- (2022) Shingo Maeda et al. Journal for ImmunoTherapy of Cancer
- Biomarkers of response to PD-1 pathway blockade
- (2022) Hanxiao Li et al. BRITISH JOURNAL OF CANCER
- Opening up new VISTAs: V-domain immunoglobulin suppressor of T cell activation (VISTA) targeted near-infrared photoimmunotherapy (NIR-PIT) for enhancing host immunity against cancers
- (2022) Hiroaki Wakiyama et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The immune checkpoint B7x expands tumor-infiltrating Tregs and promotes resistance to anti-CTLA-4 therapy
- (2022) Peter John et al. Nature Communications
- Nanodrugs Targeting T Cells in Tumor Therapy
- (2022) Maximilian Haist et al. Frontiers in Immunology
- Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer
- (2022) Alexey Revenko et al. Journal for ImmunoTherapy of Cancer
- Update in TIGIT Immune-Checkpoint Role in Cancer
- (2022) Tiziana Annese et al. Frontiers in Oncology
- GITR Antibodies in Cancer: Not Ready for Prime Time
- (2022) Tatiana Hernandez-Guerrero et al. CLINICAL CANCER RESEARCH
- T-cell immunoglobulin and ITIM domain in cancer immunotherapy: A focus on tumor-infiltrating regulatory T cells
- (2022) Xiaoyan Tian et al. MOLECULAR IMMUNOLOGY
- First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors
- (2022) Elizabeth J Davis et al. Journal for ImmunoTherapy of Cancer
- Selective targeting of GARP-LTGFβ axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8+ T cell antitumor immunity
- (2022) Anqi Li et al. Journal for ImmunoTherapy of Cancer
- Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy
- (2021) Helena Van Damme et al. Journal for ImmunoTherapy of Cancer
- Polarization of Tumor-Associated Macrophages by Nanoparticle-Loaded Escherichia coli Combined with Immunogenic Cell Death for Cancer Immunotherapy
- (2021) Baicheng Wei et al. NANO LETTERS
- Spatial cytotoxic and memory T cells in tumor predict superior survival outcomes in patients with high‐grade serous ovarian cancer
- (2021) Guodong Zhang et al. Cancer Medicine
- Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy
- (2021) Yu-Chen Wang et al. Nature Communications
- MicroRNA-15a/16-1 Prevents Hepatocellular Carcinoma by Disrupting the Communication Between Kupffer Cells and Regulatory T Cells
- (2021) Ningning Liu et al. GASTROENTEROLOGY
- Effector memory cytotoxic CD3+/CD8+/CD45RO+ T cells are predictive of good survival and a lower risk of recurrence in triple-negative breast cancer
- (2021) Xiangjie Sun et al. MODERN PATHOLOGY
- Targeting regulatory T cells in anti‐PD‐1/PD‐L1 cancer immunotherapy
- (2021) Galina Zhulai et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Targeting TREM2 on tumor-associated macrophages enhances immunotherapy
- (2021) Mikhail Binnewies et al. Cell Reports
- Relationship Between Progression‐Free Survival, Objective Response Rate, and Overall Survival in Clinical Trials of PD‐1/PD‐L1 Immune Checkpoint Blockade: A Meta‐Analysis
- (2020) Jiabu Ye et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Macrophage M1/M2 polarization
- (2020) Chen Yunna et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Immune Landscape in Tumor Microenvironment: Implications for Biomarker Development and Immunotherapy
- (2020) Karim Pérez-Romero et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells
- (2020) Min-Hee Oh et al. JOURNAL OF CLINICAL INVESTIGATION
- Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model
- (2020) Sai Ping Lau et al. Journal for ImmunoTherapy of Cancer
- Phenotypes, Functions, and Clinical Relevance of Regulatory B Cells in Cancer
- (2020) Jin Shang et al. Frontiers in Immunology
- Future of immune checkpoint inhibitors: focus on tumor immune microenvironment
- (2020) Yunlong Jia et al. Annals of Translational Medicine
- Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer
- (2020) Weiqiang Lu et al. EMBO Molecular Medicine
- Regulatory T cell targeting in cancer: Emerging strategies in immunotherapy
- (2020) Sundee Dees et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Macrophages in Organ Transplantation
- (2020) Farideh Ordikhani et al. Frontiers in Immunology
- Myeloid-derived suppressor cells are bound and inhibited by anti-thymocyte globulin
- (2019) Young Suk Lee et al. Innate Immunity
- BTK signaling drives CD1dhiCD5+ regulatory B-cell differentiation to promote pancreatic carcinogenesis
- (2019) Shipra Das et al. ONCOGENE
- First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers
- (2019) Branimir I. Sikic et al. JOURNAL OF CLINICAL ONCOLOGY
- Cell–cell contact with proinflammatory macrophages enhances the immunotherapeutic effect of mesenchymal stem cells in two abortion models
- (2019) Yanhong Li et al. Cellular & Molecular Immunology
- Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma
- (2019) Man Liu et al. GUT
- Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy
- (2019) Melvyn T. Chow et al. IMMUNITY
- AMPK activation inhibits the functions of myeloid-derived suppressor cells (MDSC): impact on cancer and aging
- (2019) Antero Salminen et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
- (2019) Takahiro Kamada et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen
- (2019) Stefanie K. Wculek et al. Journal for ImmunoTherapy of Cancer
- Bevacizumab-Based Chemotherapy Triggers Immunological Effects in Responding Multi-Treated Recurrent Ovarian Cancer Patients by Favoring the Recruitment of Effector T Cell Subsets
- (2019) Chiara Napoletano et al. Journal of Clinical Medicine
- Targeting Treg cells in cancer immunotherapy
- (2019) Atsushi Tanaka et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
- (2019) Amira A. Barkal et al. NATURE
- TMEM203 is a binding partner and regulator of STING-mediated inflammatory signaling in macrophages
- (2019) Yang Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The effects of monoclonal anti‐CD47 on RBCs, compatibility testing, and transfusion requirements in refractory acute myeloid leukemia
- (2019) C.K. Brierley et al. TRANSFUSION
- Therapeutic strategies for the costimulatory molecule OX40 in T-cell mediated immunity
- (2019) Yu Fu et al. Acta Pharmaceutica Sinica B
- Cancer Stem Cells and Targeting Strategies
- (2019) Luisa Barbato et al. Cells
- The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma
- (2019) Gregg B. Fields Cells
- Chemokines and their receptors promoting the recruitment of myeloid-derived suppressor cells into the tumor
- (2019) Bao-Hua Li et al. MOLECULAR IMMUNOLOGY
- Current Strategies to Target Tumor-Associated-Macrophages to Improve Anti-Tumor Immune Responses
- (2019) Anfray et al. Cells
- Regulatory T cells: a potential target in cancer immunotherapy
- (2018) Kohei Shitara et al. Annals of the New York Academy of Sciences
- Reduction of myeloid-derived suppressor cells reinforces the anti-solid tumor effect of recipient leukocyte infusion in murine neuroblastoma-bearing allogeneic bone marrow chimeras
- (2018) Isabelle Dierckx de Casterlé et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The role of STAT3 in leading the crosstalk between human cancers and the immune system
- (2018) Yu Wang et al. CANCER LETTERS
- Therapeutic Targeting of Sunitinib-Induced AR Phosphorylation in Renal Cell Carcinoma
- (2018) Remi Adelaiye-Ogala et al. CANCER RESEARCH
- Liposomal CpG-ODN: An in vitro and in vivo study on macrophage subtypes responses, biodistribution and subsequent therapeutic efficacy in mice models of cancers
- (2018) Sara Nikoofal-Sahlabadi et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Myeloid-derived suppressor cell: Roles in the tumor microenvironment and tumor radiotherapy
- (2018) Zhongnan Yin et al. INTERNATIONAL JOURNAL OF CANCER
- Macrophage plasticity, polarization, and function in health and disease
- (2018) Abbas Shapouri-Moghaddam et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Distal airway microbiome is associated with immunoregulatory myeloid cell responses in lung transplant recipients
- (2018) Nirmal S. Sharma et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression
- (2018) Viktor Fleming et al. Frontiers in Immunology
- Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with Ipilimumab
- (2018) Richard P. Tobin et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study
- (2018) Antoni Ribas et al. Cancer Discovery
- Anti-glucocorticoid-induced Tumor Necrosis Factor–Related Protein (GITR) Therapy Overcomes Radiation-Induced Treg Immunosuppression and Drives Abscopal Effects
- (2018) Jonathan E. Schoenhals et al. Frontiers in Immunology
- Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma
- (2018) Veronica Huber et al. JOURNAL OF CLINICAL INVESTIGATION
- Hyperprogressive disease: recognizing a novel pattern to improve patient management
- (2018) Stéphane Champiat et al. Nature Reviews Clinical Oncology
- WDFY4 is required for cross-presentation in response to viral and tumor antigens
- (2018) Derek J. Theisen et al. SCIENCE
- Critical role for Sec22b-dependent antigen cross-presentation in antitumor immunity
- (2017) Andrés Alloatti et al. JOURNAL OF EXPERIMENTAL MEDICINE
- TLR8 ligation induces apoptosis of monocytic myeloid-derived suppressor cells
- (2017) Yushe Dang et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Macrophages as Key Drivers of Cancer Progression and Metastasis
- (2017) Sebastian R. Nielsen et al. MEDIATORS OF INFLAMMATION
- Effective combinatorial immunotherapy for castration-resistant prostate cancer
- (2017) Xin Lu et al. NATURE
- cGAS is essential for the antitumor effect of immune checkpoint blockade
- (2017) Hua Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DHRS9 Is a Stable Marker of Human Regulatory Macrophages
- (2017) Paloma Riquelme et al. TRANSPLANTATION
- Inducible Activation of MyD88 and CD40 in CAR T Cells Results in Controllable and Potent Antitumor Activity in Preclinical Solid Tumor Models
- (2017) Melinda Mata et al. Cancer Discovery
- Combination of CD40 Agonism and CSF-1R Blockade Reconditions Tumor-Associated Macrophages and Drives Potent Antitumor Immunity
- (2017) Karla R. Wiehagen et al. Cancer Immunology Research
- Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy
- (2017) Michael A. Cannarile et al. Journal for ImmunoTherapy of Cancer
- Inhibition of tumor growth and metastasis by photoimmunotherapy targeting tumor-associated macrophage in a sorafenib-resistant tumor model
- (2016) Chenran Zhang et al. BIOMATERIALS
- Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX–Bevacizumab Drug Treatment Regimen
- (2016) Emeric Limagne et al. CANCER RESEARCH
- Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
- (2016) A. Martens et al. CLINICAL CANCER RESEARCH
- Expansion and Activation of CD103 + Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
- (2016) Hélène Salmon et al. IMMUNITY
- The molecular mechanisms of TLR-signaling cooperation in cytokine regulation
- (2016) Qian Liu et al. IMMUNOLOGY AND CELL BIOLOGY
- Gemcitabine reduces MDSCs, tregs and TGFβ-1 while restoring the teff/treg ratio in patients with pancreatic cancer
- (2016) Emma Eriksson et al. Journal of Translational Medicine
- Macrophage Susceptibility to Emactuzumab (RG7155) Treatment
- (2016) Leon P. Pradel et al. MOLECULAR CANCER THERAPEUTICS
- Local convection-enhanced delivery of an anti-CD40 agonistic monoclonal antibody induces antitumor effects in mouse glioma models
- (2016) Takuhiro Shoji et al. NEURO-ONCOLOGY
- Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials
- (2016) Heleen H. Van Acker et al. PHARMACOLOGY & THERAPEUTICS
- The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas
- (2016) D. F. Quail et al. SCIENCE
- Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma
- (2016) Jeffrey J. Wallin et al. Nature Communications
- Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis
- (2016) Anna-Maria Georgoudaki et al. Cell Reports
- M-CSF and GM-CSF Receptor Signaling Differentially Regulate Monocyte Maturation and Macrophage Polarization in the Tumor Microenvironment
- (2015) E. Van Overmeire et al. CANCER RESEARCH
- Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms
- (2015) Tamás Rőszer MEDIATORS OF INFLAMMATION
- Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients
- (2015) Emanuela Romano et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD11b deficiency suppresses intestinal tumor growth by reducing myeloid cell recruitment
- (2015) Qian-Qian Zhang et al. Scientific Reports
- Bottlenecks in the Efficient Use of Advanced Therapy Medicinal Products Based on Mesenchymal Stromal Cells
- (2015) Natalia Escacena et al. Stem Cells International
- Recent Aspects of Sunitinib Therapy in Patients with Metastatic Clear-Cell Renal Cell Carcinoma: a Systematic Review of the Literature
- (2015) Daniele Minardi et al. Current Urology Reports
- VISTA Regulates the Development of Protective Antitumor Immunity
- (2014) I. Le Mercier et al. CANCER RESEARCH
- OX40 engagement depletes intratumoral Tregs via activating FcγRs, leading to antitumor efficacy
- (2014) Yannick Bulliard et al. IMMUNOLOGY AND CELL BIOLOGY
- Cellular Metabolism and Macrophage Functional Polarization
- (2014) Linnan Zhu et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Dimethyl Sulfoxide Suppresses Mouse 4T1 Breast Cancer Growth by Modulating Tumor-Associated Macrophage Differentiation
- (2014) Rui Deng et al. Journal of Breast Cancer
- Regulatory T Cells and Myeloid-Derived Suppressor Cells in the Tumor Microenvironment Undergo Fas-Dependent Cell Death during IL-2/ CD40 Therapy
- (2014) J. M. Weiss et al. JOURNAL OF IMMUNOLOGY
- Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers
- (2014) Francois Moisan et al. Molecular Oncology
- Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer
- (2014) Khaled Ali et al. NATURE
- Setback for JAK2 inhibitors
- (2014) Mark Ratner NATURE BIOTECHNOLOGY
- Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice
- (2014) Hong Qin et al. NATURE MEDICINE
- Is there new hope for therapeutic matrix metalloproteinase inhibition?
- (2014) Roosmarijn E. Vandenbroucke et al. NATURE REVIEWS DRUG DISCOVERY
- Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma
- (2014) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of Tumor Angiogenesis by Interferon-γ by Suppression of Tumor-Associated Macrophage Differentiation
- (2014) Tao Sun et al. ONCOLOGY RESEARCH
- Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity
- (2013) Andrea Casazza et al. CANCER CELL
- A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors
- (2013) Shahneen K. Sandhu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
- (2013) Tyler R. Simpson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CSF-1R inhibition alters macrophage polarization and blocks glioma progression
- (2013) Stephanie M Pyonteck et al. NATURE MEDICINE
- Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans
- (2013) D. Sugiyama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells
- (2013) M. J. Selby et al. Cancer Immunology Research
- Trabectedin
- (2013) Paola Allavena et al. OncoImmunology
- Thymosin α1 and cancer: action on immune effector and tumor target cells
- (2012) Enrico Garaci et al. Annals of the New York Academy of Sciences
- Aptamer-Mediated Blockade of IL4R Triggers Apoptosis of MDSCs and Limits Tumor Progression
- (2012) F. Roth et al. CANCER RESEARCH
- CD25 Blockade Depletes and Selectively Reprograms Regulatory T Cells in Concert with Immunotherapy in Cancer Patients
- (2012) A. J. Rech et al. Science Translational Medicine
- Mesenchymal stem cells engineered for cancer therapy
- (2011) Khalid Shah ADVANCED DRUG DELIVERY REVIEWS
- Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment
- (2011) P. Allavena et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Targeted delivery of oligonucleotides into tumor-associated macrophages for cancer immunotherapy
- (2011) Zhen Huang et al. JOURNAL OF CONTROLLED RELEASE
- High number of CD45RO+ tumor infiltrating lymphocytes is an independent prognostic factor in non-metastasized (stage I-IIA) esophageal adenocarcinoma
- (2010) Sandra Rauser et al. BMC CANCER
- Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects
- (2010) W. Zhang et al. CLINICAL CANCER RESEARCH
- Tremelimumab (anti-CTLA4) mediates immune responses mainly by direct activation of T effector cells rather than by affecting T regulatory cells
- (2010) Sameena Khan et al. CLINICAL IMMUNOLOGY
- Inflammatory Cytokine-Induced Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1 in Mesenchymal Stem Cells Are Critical for Immunosuppression
- (2010) Guangwen Ren et al. JOURNAL OF IMMUNOLOGY
- The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity
- (2010) Matthew A Bill et al. Molecular Cancer
- PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
- (2010) M. A. Curran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis
- (2009) Julia Bollrath et al. CANCER CELL
- Targeting tumor-associated macrophages in an experimental glioma model with a recombinant immunotoxin to folate receptor β
- (2009) Taku Nagai et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
- (2009) Ravindra Majeti et al. CELL
- Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation
- (2007) Karen English et al. IMMUNOLOGY LETTERS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started